PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
59.45%
Revenue growth at 50-75% of OGI.TO's 116.53%. Martin Whitman would worry about competitiveness or product relevance.
-53.84%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-103.69%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-103.69%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
153.01%
Positive net income growth while OGI.TO is negative. John Neff might see a big relative performance advantage.
141.84%
Positive EPS growth while OGI.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
141.84%
Positive diluted EPS growth while OGI.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
8.51%
Share count expansion well above OGI.TO's 1.69%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
8.22%
Slight or no buyback while OGI.TO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
89.50%
OCF growth above 1.5x OGI.TO's 48.98%. David Dodd would confirm a clear edge in underlying cash generation.
24.16%
FCF growth above 1.5x OGI.TO's 3.14%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
63.82%
3Y revenue/share CAGR under 50% of OGI.TO's 718.40%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-109.34%
Negative 10Y OCF/share CAGR while OGI.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-273.64%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-202.53%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
3051.78%
10Y net income/share CAGR of 3051.78% while OGI.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
11082.24%
Positive 5Y CAGR while OGI.TO is negative. John Neff might view this as a strong mid-term relative advantage.
2188.69%
Positive short-term CAGR while OGI.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
3410.56%
Equity/share CAGR of 3410.56% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
16854.11%
Below 50% of OGI.TO's 36192.23%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
448.58%
Below 50% of OGI.TO's 968.68%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.98%
AR growth is negative/stable vs. OGI.TO's 90.19%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
13.55%
We show growth while OGI.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
26.26%
Asset growth above 1.5x OGI.TO's 2.04%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
10.83%
50-75% of OGI.TO's 16.88%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-3.57%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
128.48%
R&D growth of 128.48% while OGI.TO is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
15.04%
SG&A declining or stable vs. OGI.TO's 77.03%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.